An article titled “More expanded drug indications approved on less rigorous evidence” (published September 24, 2015) misstated the review’s findings regarding testing of drugs. An extensive review of publicly available Food and Drug Administration records concluded that few of these drugs rely on the more rigorous clinical trials intended to screen out ineffectively or potentially harmful drugs.